Barinthus Biotherapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -854 | -907 | -2,024 | |
EBITDA | -4,821 | -10,339 | -13,428 | -19,138 |
EBIT | -5,676 | -11,246 | -14,629 | -21,139 |
Net Income | -5,521 | -11,073 | -14,566 | -21,124 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,366 | -4,196 | -10,726 | -18,141 |
Cash | 67,189 | 70,456 | 74,272 | 86,259 |
Basic Shares | 40,848 | 40,527 | 40,661 | 40,343 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $14,969 | $802 | $44,703 |
Gross Profit | -5,858 | 14,969 | 802 | 44,703 |
EBITDA | -62,897 | -55,374 | -71,065 | 5,192 |
EBIT | -68,742 | -61,174 | -76,494 | 869 |
Net Income | -66,583 | -61,074 | -73,347 | 5,342 |
Net Change In Cash | 0 | 14,969 | 802 | 44,703 |
Free Cash Flow | -48,016 | -29,832 | -56,338 | -20,569 |
Cash | 70,456 | 110,662 | 142,090 | 194,385 |
Basic Shares | 40,527 | 39,348 | 38,386 | 38,169 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.14 |
2025-12-31 | -$0.27 |
2025-09-30 | -$0.36 |
2025-06-30 | -$0.52 |